FDA drops black box warning on Pfizer's anti-smoking drug

Dec 16 (Reuters) - U.S. health regulators on Friday allowed

Pfizer Inc to remove a serious warning from the label of

its smoking cessation treatment, Chantix, giving a new lease of

life to the controversial drug that was approved a decade ago.

Read more